Obeticholic acid does not restore Western diet-induced alterations in hepatic mitochondrial respiration
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F25%3A10504265" target="_blank" >RIV/00216208:11160/25:10504265 - isvavai.cz</a>
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=1DYwEL63nf" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=1DYwEL63nf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.biopha.2025.118542" target="_blank" >10.1016/j.biopha.2025.118542</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Obeticholic acid does not restore Western diet-induced alterations in hepatic mitochondrial respiration
Popis výsledku v původním jazyce
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects a significant portion of the global population, with mitochondrial dysfunction playing a pivotal role in its pathogenesis. Although FXR agonists such as obeticholic acid (OCA) have been studied as potential treatments for MASLD, the direct effects of OCA on the liver are still not fully understood. This study aimed to evaluate the effects of OCA in an in vivo model of MASLD. Methods: Male C57BL/6 J mice were fed a control diet (CD) or a Western diet (WD) enriched with glucose and fructose in the drinking water for 36 weeks. During the final 3 weeks, mice received OCA (5 or 10 mg/kg/day) or vehicle. Liver histology, biochemical parameters, gene expression, mitochondrial enzymes activity and mitochondrial respiration were assessed. Results: WD-fed mice exhibited increased body and liver weights and elevated aminotransferases, none of which were altered by OCA. OCA treatment did not significantly impact steatosis, inflammation, fibrosis, or hepatic lipid content. WD feeding reduced succinate-stimulated hepatic mitochondrial respiration, associated with decreased succinate dehydrogenase (SDH) expression and activity. OCA partially restored Sdh subunits B and C expression but did not significantly improve respirometric parameters. Conclusion: Our findings consistently demonstrate that OCA administration in an established diet-induced murine model of MASLD does not improve hepatic steatosis or inflammation. Moreover, the WD-induced decrease in succinate-stimulated mitochondrial respiration was not ameliorated by OCA.
Název v anglickém jazyce
Obeticholic acid does not restore Western diet-induced alterations in hepatic mitochondrial respiration
Popis výsledku anglicky
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects a significant portion of the global population, with mitochondrial dysfunction playing a pivotal role in its pathogenesis. Although FXR agonists such as obeticholic acid (OCA) have been studied as potential treatments for MASLD, the direct effects of OCA on the liver are still not fully understood. This study aimed to evaluate the effects of OCA in an in vivo model of MASLD. Methods: Male C57BL/6 J mice were fed a control diet (CD) or a Western diet (WD) enriched with glucose and fructose in the drinking water for 36 weeks. During the final 3 weeks, mice received OCA (5 or 10 mg/kg/day) or vehicle. Liver histology, biochemical parameters, gene expression, mitochondrial enzymes activity and mitochondrial respiration were assessed. Results: WD-fed mice exhibited increased body and liver weights and elevated aminotransferases, none of which were altered by OCA. OCA treatment did not significantly impact steatosis, inflammation, fibrosis, or hepatic lipid content. WD feeding reduced succinate-stimulated hepatic mitochondrial respiration, associated with decreased succinate dehydrogenase (SDH) expression and activity. OCA partially restored Sdh subunits B and C expression but did not significantly improve respirometric parameters. Conclusion: Our findings consistently demonstrate that OCA administration in an established diet-induced murine model of MASLD does not improve hepatic steatosis or inflammation. Moreover, the WD-induced decrease in succinate-stimulated mitochondrial respiration was not ameliorated by OCA.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30105 - Physiology (including cytology)
Návaznosti výsledku
Projekt
Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2025
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Biomedicine & Pharmacotherapy
ISSN
0753-3322
e-ISSN
1950-6007
Svazek periodika
192
Číslo periodika v rámci svazku
NOV
Stát vydavatele periodika
FR - Francouzská republika
Počet stran výsledku
10
Strana od-do
118542
Kód UT WoS článku
999
EID výsledku v databázi Scopus
2-s2.0-105016255577